Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · February 19, 2024

Outcomes of Treatment With Dupilumab in Patients With Atopic Hand and Foot Dermatitis

Journal of the American Academy of Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Dupilumab treatment improves signs, symptoms, quality of life and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial
J Am Acad Dermatol 2024 Jan 29;[EPub Ahead of Print], EL Simpson, JI Silverberg, M Worm, G Honari, K Masuda, E Sygula, MLA Schuttelaar, E Mortensen, E Laws, B Akinlade, N Patel, J Maloney, H Paleczny, D Delevry, J Xiao, A Dubost-Brama, A Bansal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading